-
Subject Areas on Research
-
68Ga-DOTATATE: Significance of Uptake in the Tail of the Pancreas in Patients Without Lesions.
-
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.
-
A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma.
-
A literature-based treatment algorithm for low-grade neuroendocrine liver metastases.
-
A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.
-
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.
-
A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
-
ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
-
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
-
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
-
ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas.
-
Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.
-
Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.
-
Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.
-
Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms.
-
Choroidal metastatasis from a neuroendocrine tumor masquerading as choroidal melanoma.
-
Comment on "Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment".
-
Competing Mortality in Patients With Neuroendocrine Tumors.
-
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
-
Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.
-
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.
-
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
-
EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.
-
Early onset pancreatic malignancies: Clinical characteristics and survival associations.
-
Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.
-
Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression.
-
Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.
-
Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors.
-
Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.
-
Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
-
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
-
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
-
Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
-
Immunohistochemical characterization of neuroendocrine cells in prostate cancer.
-
Impact of Peritoneal Metastasis on Survival of Patients With Small Intestinal Neuroendocrine Tumor.
-
Impact of Point-Spread Function Reconstruction on 68Ga-DOTATATE PET/CT Quantitative Imaging Parameters.
-
Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
-
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
-
In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.
-
Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.
-
Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.
-
Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
-
Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB.
-
LIN28B promotes the development of neuroendocrine prostate cancer.
-
Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors.
-
Lipid-rich variant of a pancreatic endocrine neoplasm in an endoscopic ultrasound-guided fine needle aspiration biopsy.
-
Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases.
-
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors.
-
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.
-
MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate.
-
Management of advanced neuroendocrine tumors with hepatic metastasis.
-
Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
-
Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
-
Molecular Imaging and Therapy for Neuroendocrine Tumors.
-
Molecular Imaging in the Head and Neck: Diagnosis and Therapy.
-
Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.
-
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.
-
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.
-
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
-
NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network.
-
Neuroendocrine Neoplasms of the Appendix: A Review of the Literature.
-
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT.
-
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
-
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.
-
Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy.
-
Neuroendocrine tumors of the gastrointestinal tract and the role of cytotoxic chemotherapy.
-
Neuroendocrine tumors, version 1.2015.
-
Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
-
O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors.
-
Objective radiological disease control with sandostatin monotherapy in metastatic neuroendocrine tumours.
-
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.
-
Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
-
Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
-
PET-Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors.
-
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies.
-
Pancreatic FNA in 1000 cases: a comparison of imaging modalities.
-
Pancreatic Neuroendocrine Tumors.
-
Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.
-
Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
-
Pancreatic neuroendocrine tumors: pathologic and molecular characteristics.
-
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
-
Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey.
-
Platinum sensitivity in metastatic prostate cancer: does histology matter?
-
Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.
-
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
-
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBG.
-
Primary Breast Neuroendocrine Tumor.
-
Proceed with caution: liver transplantation for metastatic neuroendocrine tumors.
-
RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.
-
Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy.
-
Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver.
-
SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
-
SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms.
-
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
-
Section Editor's Notebook: 68
Ga- and 177
Lu-DOTATATE Theragnostics-Personalized Care and Improving Patient Outcomes.
-
Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
-
Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.
-
Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?
-
Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
-
Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
-
Synchronous resection of primary and liver metastases for neuroendocrine tumors.
-
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors.
-
The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors.
-
The Role of Surgery for Pancreatic Neuroendocrine Tumors.
-
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
-
The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia.
-
Therapy With 177
Lu-DOTATATE: Clinical Implementation and Impact on Care of Patients With Neuroendocrine Tumors.
-
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.
-
Two Extraordinary Sellar Neuronal Tumors: Literature Review and Comparison of Clinicopathologic Features.
-
Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
-
Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases.
-
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
-
Whole-Genome and Transcriptional Analysis of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer Demonstrates Intraclass Heterogeneity.
-
mRNA profiling of a well-differentiated G1 pancreatic NET correlates with immunohistochemistry profile: a case report.
-
Keywords of People